These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 22115555)
1. Ionizing radiation promotes migration and invasion of cancer cells through transforming growth factor-beta-mediated epithelial-mesenchymal transition. Zhou YC; Liu JY; Li J; Zhang J; Xu YQ; Zhang HW; Qiu LB; Ding GR; Su XM; Mei-Shi ; Guo GZ Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1530-7. PubMed ID: 22115555 [TBL] [Abstract][Full Text] [Related]
2. TGF-beta1 causes epithelial-mesenchymal transition in HaCaT derivatives, but induces expression of COX-2 and migration only in benign, not in malignant keratinocytes. Räsänen K; Vaheri A J Dermatol Sci; 2010 May; 58(2):97-104. PubMed ID: 20399617 [TBL] [Abstract][Full Text] [Related]
3. TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT). Kasai H; Allen JT; Mason RM; Kamimura T; Zhang Z Respir Res; 2005 Jun; 6(1):56. PubMed ID: 15946381 [TBL] [Abstract][Full Text] [Related]
4. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis. Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760 [TBL] [Abstract][Full Text] [Related]
5. Low doses ionizing radiation enhances the invasiveness of breast cancer cells by inducing epithelial-mesenchymal transition. Zhang X; Li X; Zhang N; Yang Q; Moran MS Biochem Biophys Res Commun; 2011 Aug; 412(1):188-92. PubMed ID: 21810413 [TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition. Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177 [TBL] [Abstract][Full Text] [Related]
7. EW-7203, a novel small molecule inhibitor of transforming growth factor-β (TGF-β) type I receptor/activin receptor-like kinase-5, blocks TGF-β1-mediated epithelial-to-mesenchymal transition in mammary epithelial cells. Park CY; Kim DK; Sheen YY Cancer Sci; 2011 Oct; 102(10):1889-96. PubMed ID: 21707864 [TBL] [Abstract][Full Text] [Related]
8. Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomy. Zhang Q; Helfand BT; Jang TL; Zhu LJ; Chen L; Yang XJ; Kozlowski J; Smith N; Kundu SD; Yang G; Raji AA; Javonovic B; Pins M; Lindholm P; Guo Y; Catalona WJ; Lee C Clin Cancer Res; 2009 May; 15(10):3557-67. PubMed ID: 19447876 [TBL] [Abstract][Full Text] [Related]
9. The Src family kinase inhibitors PP2 and PP1 effectively block TGF-beta1-induced cell migration and invasion in both established and primary carcinoma cells. Bartscht T; Lehnert H; Gieseler F; Ungefroren H Cancer Chemother Pharmacol; 2012 Aug; 70(2):221-30. PubMed ID: 22699812 [TBL] [Abstract][Full Text] [Related]
11. Identification of two distinct carcinoma-associated fibroblast subtypes with differential tumor-promoting abilities in oral squamous cell carcinoma. Costea DE; Hills A; Osman AH; Thurlow J; Kalna G; Huang X; Pena Murillo C; Parajuli H; Suliman S; Kulasekara KK; Johannessen AC; Partridge M Cancer Res; 2013 Jul; 73(13):3888-901. PubMed ID: 23598279 [TBL] [Abstract][Full Text] [Related]
12. Halofuginone inhibits radiotherapy-induced epithelial-mesenchymal transition in lung cancer. Chen Y; Liu W; Wang P; Hou H; Liu N; Gong L; Wang Y; Ji K; Zhao L; Wang P Oncotarget; 2016 Nov; 7(44):71341-71352. PubMed ID: 27533085 [TBL] [Abstract][Full Text] [Related]
13. TGF-β1 mediates epithelial to mesenchymal transition via the TGF-β/Smad pathway in squamous cell carcinoma of the head and neck. Yu C; Liu Y; Huang D; Dai Y; Cai G; Sun J; Xu T; Tian Y; Zhang X Oncol Rep; 2011 Jun; 25(6):1581-7. PubMed ID: 21479366 [TBL] [Abstract][Full Text] [Related]
14. Thyroid transcription factor-1 inhibits transforming growth factor-beta-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells. Saito RA; Watabe T; Horiguchi K; Kohyama T; Saitoh M; Nagase T; Miyazono K Cancer Res; 2009 Apr; 69(7):2783-91. PubMed ID: 19293183 [TBL] [Abstract][Full Text] [Related]
15. Ganglioside GM3 participates in the TGF-β1-induced epithelial-mesenchymal transition of human lens epithelial cells. Kim SJ; Chung TW; Choi HJ; Kwak CH; Song KH; Suh SJ; Kwon KM; Chang YC; Park YG; Chang HW; Kim KS; Kim CH; Lee YC Biochem J; 2013 Jan; 449(1):241-51. PubMed ID: 23050851 [TBL] [Abstract][Full Text] [Related]
16. Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression. Gordon KJ; Dong M; Chislock EM; Fields TA; Blobe GC Carcinogenesis; 2008 Feb; 29(2):252-62. PubMed ID: 17999987 [TBL] [Abstract][Full Text] [Related]
17. An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition. Park CY; Min KN; Son JY; Park SY; Nam JS; Kim DK; Sheen YY Cancer Lett; 2014 Aug; 351(1):72-80. PubMed ID: 24887560 [TBL] [Abstract][Full Text] [Related]